Biotech startups in Redwood City, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Welltory | Redwood City | Seed | $2.0M | 2026-10-08 |
| Karius | Redwood City | Series C | $100.0M | 2024-05-02 |
| Flashpoint Therapeutics | Redwood City | Seed | $10.0M | 2023-10-25 |
| N-Power Medicine | Redwood City | Series B | $32.0M | 2026-09-01 |
| Integrated Biosciences | Redwood City | Series A | $68.4M | 2026-08-05 |
| Synthego | Redwood City | Series E | $200.0M | 2022-02-17 |
| Cellanome | Redwood City | Series C | $75.9M | 2026-06-18 |
| Mosanna Therapeutics | Redwood City | Series A | $80.0M | 2025-06-09 |
8 rows of the CSV in 5 of its 18 columns.
- The 39 biotech startups in Redwood City, United States have raised $3.1B in total.
- 7 of them closed their most recent round in the last 12 months, $241.8M combined.
- The largest of those rounds is Cellanome's $75.9M Series C, dated June 2026.
- The most recent is Familiar's $5.0M seed round on 21 October 2026.
- Health care is the most common other sector, with 34 companies (87%).
- 26% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (41% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
8 of 39| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Welltory | Welltory produces AI-powered wellness apps for digital health tracking. | Artificial intelligence | Seed | $2.0M | 2026-10-08 | $16.3M | Goodwater Capital, JOINT JOURNEY, CABRA VC | 51 to 100 | 2016 |
| N-Power Medicine | N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. | Artificial intelligence | Series B | $32.0M | 2026-09-01 | $104.0M | Merck Global Health Innovation Fund | 101 to 250 | 2021 |
| Integrated Biosciences | Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. | Artificial intelligence | Series A | $68.4M | 2026-08-05 | $85.6M | Root Ventures, Reinforced Ventures, Mission BioCapital +2 | 11 to 50 | 2022 |
| Cellanome | Cellanome uses synthetic biology and informatics methods to analyze multi-omics data. | Biotech | Series C | $75.9M | 2026-06-18 | $289.6M | Premji Invest, Synetro Group | 51 to 100 | 2020 |
| Mosanna Therapeutics | Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea. | Biotech | Series A | $80.0M | 2025-06-09 | $80.0M | HTGF (High-Tech Gruenderfonds), Supermoon Capital | 1 to 10 | 2022 |
| Karius | Karius delivers genomic insights into infectious diseases to guide clinical treatment decisions. | Artificial intelligence | Series C | $100.0M | 2024-05-02 | $354.0M | Lightspeed Venture Partners, General Catalyst, Khosla Ventures +1 | 101 to 250 | 2014 |
| Flashpoint Therapeutics | Flashpoint Therapeutics develops a new approach to building cancer immunotherapies. | Biotech | Seed | $10.0M | 2023-10-25 | $10.0M | Beta Lab, CS Venture Opportunities Fund | 1 to 10 | 2022 |
| Synthego | Synthego provides genome engineering services and CRISPR tools for life science research. | Artificial intelligence | Series E | $200.0M | 2022-02-17 | $459.7M | Intel Capital, Founders Fund, Menlo Ventures +2 | 101 to 250 | 2012 |
Table 1. Biotech startups in Redwood City, United States: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 39.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cellanome | Cellanome uses synthetic biology and informatics methods to analyze multi-omics data. | Biotech | Series C | $75.9M | 2026-06-18 | $289.6M | Premji Invest, Synetro Group | 51 to 100 | 2020 |
| 2 | Integrated Biosciences | Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. | Artificial intelligence | Series A | $68.4M | 2026-08-05 | $85.6M | Root Ventures, Reinforced Ventures, Mission BioCapital +2 | 11 to 50 | 2022 |
| 3 | N-Power Medicine | N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. | Artificial intelligence | Series B | $32.0M | 2026-09-01 | $104.0M | Merck Global Health Innovation Fund | 101 to 250 | 2021 |
| 4 | Welltory | Welltory produces AI-powered wellness apps for digital health tracking. | Artificial intelligence | Seed | $2.0M | 2026-10-08 | $16.3M | Goodwater Capital, JOINT JOURNEY, CABRA VC | 51 to 100 | 2016 |
Table 2. Biotech startups in Redwood City, United States: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Goodwater Capital | Venture capital firm | Burlingame, United States | 1 | 3% | 1 | Welltory |
| 2 | JOINT JOURNEY | Syndicate | Limassol, Cyprus | 1 | 3% | 1 | Welltory |
| 3 | CABRA VC | Venture capital firm | Limassol, Cyprus | 1 | 3% | 1 | Welltory |
| 4 | Lightspeed Venture Partners | Venture capital firm | Menlo Park, United States | 1 | 3% | ||
| 5 | General Catalyst | Venture capital firm | San Francisco, United States | 1 | 3% | ||
| 6 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 1 | 3% | ||
| 7 | DCVC | Venture capital firm | Palo Alto, United States | 1 | 3% | ||
| 8 | CS Venture Opportunities Fund | Private equity firm | New York, United States | 1 | 3% | ||
| 9 | Beta Lab | Venture capital firm | Riyadh, Saudi Arabia | 1 | 3% | ||
| 10 | Merck Global Health Innovation Fund | Corporate venture arm | Whitehouse Station, United States | 1 | 3% | 1 | N-Power Medicine |
| 11 | Reinforced Ventures | Venture capital firm | Pittsburgh, United States | 1 | 3% | 1 | Integrated Biosciences |
| 12 | Polymath Capital | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Integrated Biosciences |
| 13 | Root Ventures | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Integrated Biosciences |
| 14 | Mission BioCapital | Venture capital firm | Cambridge, United States | 1 | 3% | 1 | Integrated Biosciences |
| 15 | Conscience VC | Venture capital firm | Austin, United States | 1 | 3% | 1 | Integrated Biosciences |
Table 3. Biotech startups in Redwood City, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 34 | 87% | $2.8B |
| Software | 7 | 18% | $1.1B |
| Artificial intelligence | 5 | 13% | $1.0B |
| Hardware | 1 | 3% | $5.2M |
Table 4. Biotech startups in Redwood City, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 1 | 3% | |
| Seed | 9 | 23% | $2.0M |
| Series A | 6 | 15% | $68.4M |
| Series B | 9 | 23% | $32.0M |
| Series C | 5 | 13% | $75.9M |
| Series D+ | 9 | 23% | $27.0M |
Table 5. Biotech startups in Redwood City, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 29% | $7.0M |
| September 2026 | 2 | 29% | $57.0M |
| August 2026 | 1 | 14% | $68.4M |
| June 2026 | 1 | 14% | $75.9M |
| January 2026 | 1 | 14% | $33.5M |
Table 6. Biotech startups in Redwood City, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 18% | $241.8M |
| 2025 | 2 | 5% | $130.0M |
| 2024 | 3 | 8% | $261.0M |
| 2023 | 1 | 3% | $10.0M |
| 2022 | 4 | 10% | $202.0M |
| 2021 | 4 | 10% | $102.0M |
Table 7. Biotech startups in Redwood City, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 5% |
| 2020 to 2022 | 8 | 21% |
| 2015 to 2019 | 11 | 28% |
| 2010 to 2014 | 9 | 23% |
| Before 2010 | 9 | 23% |
Table 8. Biotech startups in Redwood City, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 14 | 36% |
| 11 to 50 | 16 | 41% |
| 51 to 100 | 3 | 8% |
| 101 to 250 | 4 | 10% |
| 501 to 1,000 | 1 | 3% |
| 5,001 to 10,000 | 1 | 3% |
Table 9. Biotech startups in Redwood City, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Redwood City, United States. On 16 November 2026 that is 39 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 8 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 39 rows: 5 have no round amount, 0 no city and 2 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Redwood City, United States are on the list?
- 39, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 39 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.